Recruiting Dravet Syndrome Studies in Ann Arbor
About Dravet Syndrome Clinical Trials in Ann Arbor
Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.
There are currently 2 dravet syndrome clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 79 participants. Research is being sponsored by Encoded Therapeutics, Ionis Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dravet Syndrome Clinical Trials in Ann Arbor — FAQ
Are there dravet syndrome clinical trials in Ann Arbor?
Yes, there are 2 dravet syndrome clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What dravet syndrome treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.
Data updated October 15, 2026 from ClinicalTrials.gov